Human herpesvirus-8 (Kaposi’s sarcoma-associated herpesvirus) ORF50 interacts synergistically with the tat gene product in transactivating the human immunodeficiency virus type 1 LTR

References

1. Bello L. J., Davison A. J., Glenn M. A., Whitehouse A., Rethmeier N., Schulz T. F., Clements J. B. 1999; The human herpesvirus-8 ORF57 gene and its properties. Journal of General Virology 80:3207–3215
   [Google Scholar]
2. Biggar R. J., Rosemberg P. S., Cotè T. 1996; AIDS/cancer match study group. Kaposi’s sarcoma and non-Hodgkin’s lymphoma following the diagnosis of AIDS. International Journal of Cancer 68:754–58
   [Google Scholar]
3. Buisson M., Manet E., Trescol-Biemont M. C., Gruffat H., Durand B., Sergeant A. 1989; The Epstein–Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R. Journal of Virology 63:5276–5284
   [Google Scholar]
4. Caputo A., Sodroski J. G., Haseltine W. A. 1990; Constitutive expression of HIV-1 Tat protein in human Jurkat T cells using a BK virus vector. Journal of Acquired Immune Deficiency Syndromes 3:372–379
   [Google Scholar]
5. Caputo A., Grossi M. P., Bozzini R., Rossi C., Betti M., Marconi P. C., Barbanti-Brodano G., Balboni P. G. 1996; Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region. Gene Therapy 3:235–245
   [Google Scholar]
6. Caputo A., Betti M., Boarini C., Mantovani I., Corallini A., Barbanti-Brodano G. 1999; Multiple functions of human immunodeficiency virus type 1 Tat protein in the pathogenesis of AIDS. Recent Research and Development in Virology 1:753–771
   [Google Scholar]
7. Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. 1995; Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New England Journal of Medicine 332:1186–1191
   [Google Scholar]
8. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. 1994; Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266:1865–1869
   [Google Scholar]
9. Cooper M., Goodwin D. J., Hall K. T., Stevenson A. J., Meredith D. M., Alexander F. M., Whitehouse A. 1999; The gene product encoded by ORF57 of herpesvirus saimiri regulates the redistribution of the splicing factor SC-35. Journal of General Virology 80:1311–1316
   [Google Scholar]
10. Davis L. G., Dibner M. D. Battey J. F. (editors) 1986 Basic Methods in Molecular Biology New York: Elsevier Science Publishing;
11. Grossi M. P., Caputo A., Rimessi P., Chiccoli L., Balboni P. G., Barbanti-Brodano G. 1988; New BK virus episomal vector for complementary DNA expression in human cells. Archives of Virology 102:275–283
    [Google Scholar]
12. Harrington W. Jr, Sieczkowski L., Sosa C., Chan-a-Sue S., Cai J. P., Cabral L., Wood C. 1997; Activation of HHV-8 by HIV-1 Tat. Lancet 349:774–775
    [Google Scholar]
13. Kirshner J. R., Lukac D., Chang J., Ganem D. 2000; Kaposi’s sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. Journal of Virology 74:3586–3597
    [Google Scholar]
14. Lukac D. M., Renne R., Kirshner J. R., Ganem D. 1998; Reactivation of Kaposi’s sarcoma associated herpesvirus from latency by expression of the ORF50 transactivator, a homolog of the EBV R protein. Virology 282:304–312
    [Google Scholar]
15. Lukac D. N., Kirshner J. R., Ganem D. 1999; Transcriptional activation by the product of open reading frame 50 of Kaposi’s sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. Journal of Virology 73:9348–9361
    [Google Scholar]
16. Moir S., Lapointe R., Malaspina A., Ostrowski M., Cole C. E., Chun T-W., Adelsberger J., Baseler M., Hwu P., Fauci A. S. 1999; CD40-mediated induction of CD4 and XCXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir. Journal of Virology 73:7072–7980
    [Google Scholar]
17. Moir S., Malaspina A., Li Y., Chun T-W., Lowe T., Adelsberger J., Baseler M., Ehler L. A., Liu S., Davey R. T., Mican J. A., Fauci A. S. 2000; B cells of HIV-1-infected patients binds virions through CD21-complement interactions and transmit infectious virus to activated T cells. Journal of Experimental Medicine 192:637–646
    [Google Scholar]
18. Monini P., Colombini S., Sturzl M., Goletti D., Cafaro A., Sgadari C., Butto S., Franco M., Leone P., Fais S., Leone P., Melucci-Vigo G., Chiozzini C., Carlini F., Ascherl G., Cornali E., Zietz C., Ramazotti E., Ensoli F., Andreoni M., Pezzotti P., Reza G., Yarchoan R., Gallo R. C., Ensoli B. 1999; Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi’s sarcoma. Blood 93:4044–4058
    [Google Scholar]
19. Moore A. Y., Hudnale S. D., Rady P. L., Wagner R. F., Moore T. O. Jr, Memar O., Hughes T. K., Tyring S. K. 2000; Differential expression of the HHV-8 vGCR cellular homolog gene in AIDS-associated and classic Kaposi’s sarcoma: potential role of HIV-1 Tat. Virology 267:247–251
    [Google Scholar]
20. Okamoto H., Sheline C. T., Corden J. L., Jones K. A., Peterlin B. M. 1996; Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proceedings of the National Academy of Sciences, USA 93:11575–11579
    [Google Scholar]
21. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., Ganem D. 1996; Lytic growth of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Medicine 2:342–346
    [Google Scholar]
22. Schulz T. 1998; Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8). Journal of General Virology 79:1573–1591
    [Google Scholar]
23. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d’Agay M. F., Clauvel J. P., Raphael M., Degos L., Sigaux F. 1995; Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86:1276–1280
    [Google Scholar]
24. Staskus K. A., Zhong W., Gebhard K., Herndier B., Wang H., Renne R., Beneke J., Pudney J., Anderson D. J., Ganem D., Haase A. T. 1997; Kaposi’s sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. Journal of Virology 71:715–719
    [Google Scholar]
25. Varthakavi V., Browning P. J., Spearman P. 1999; Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulate lytic-phase replication of Kaposi’s sarcoma-associated herpesvirus. Journal of Virology 73:10329–10338
    [Google Scholar]
26. Whitby D., Howard M. R., Tenant-Flowers M., Brink N. S., Copas A., Boshoff C., Hatzioannou T., Suggett F. E., Aldam D. M., Denton A. S. and others 1995; Detection of Kaposi’s sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi’s sarcoma. Lancet 346:799–802
    [Google Scholar]
27. Whitehouse A., Cooper M., Hall K. T., Meredith D. M. 1998a; The open reading frame (ORF) 50a gene product regulates ORF57 gene expression in herpesvirus saimiri. Journal of Virology 72:1967–1973
    [Google Scholar]
28. Whitehouse A., Cooper M., Meredith D. M. 1998b; The immediate-early gene product encoded by open reading frame 57 of herpesvirus saimiri modulates gene expression at a posttranscriptional level. Journal of Virology 72:857–861
    [Google Scholar]
29. Wright C. M., Felber B. K., Paskalis H., Pavlakis G. N. 1986; Expression and characterization of the trans-activator of HTLV-III/LAV virus. Science 234:988–992
    [Google Scholar]
30. Zhou Q., Chen D., Pierstorff E., Luo K. 1998; Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO Journal 17:3681–3691
    [Google Scholar]